K
Ketryx
Offering a platform to simplify FDA compliance and safety for regulated medical software development
About Ketryx
Ketryx is a startup that provides a specialized software platform designed to streamline the development and compliance processes for medical software applications. The company operates in the medical technology (MedTech) sector, focusing on clients who develop regulated medical software, including startups and large enterprises. Ketryx's platform is particularly beneficial for companies that need to adhere to stringent regulatory standards such as FDA regulations, IEC 62304, GMP, ISO 13485, and CFR 21 Part 11.
Read full description
The core offering of Ketryx is its Connected Lifecycle Management platform, which helps clients manage the entire lifecycle of their medical software products. This includes ensuring compliance with regulatory requirements, improving product quality, and accelerating time to market. The platform integrates various tools and capabilities such as traceability, documentation, Jira integration, and Software Bill of Materials (SBOM) management. These features help clients maintain compliance and manage their product development processes more efficiently.
Ketryx's business model is based on a Software-as-a-Service (SaaS) approach. Clients subscribe to the platform and pay for access to its suite of tools and services. This subscription model provides Ketryx with a steady stream of recurring revenue. Additionally, the company offers various pricing tiers to cater to different sizes of organizations, from startups to large enterprises.
In summary, Ketryx simplifies the complex process of developing and maintaining FDA-compliant medical software. By providing a comprehensive platform that integrates essential compliance and lifecycle management tools, Ketryx helps its clients reduce costs, mitigate compliance risks, and bring their products to market faster.
At a glance
- Status
- Operational
- Founded
- 2021
- Headquarters
- Cambridge, United States
- Employees
- 144
- Open positions
- 7
- Dealroom signal
- 92.8/100
- Industry
- Health, Legal
- Sub-industry
- Medical Devices, Health Platform, RegTech & Compliance
- Sector
- Health Tech & Medtech, Medical Data, Hard Tech, Health It
- Business model
- SaaS
- Client focus
- b2b
Latest news
Press, funding announcements and product moves mentioning Ketryx.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES BOther financing | Sep 2025 | $39M | $156M | Lightspeed Venture Partners · Ubiquity Ventures · Fifty Three Stations · E14 Fund | ↗ |
| SERIES AOther financing | Dec 2023 | $14M | $56M | E14 Fund · Ubiquity Ventures · Lightspeed Venture Partners | ↗ |
Growth signals
Latest recorded traffic for Ketryx is 32K monthly website visits, down 22% over the last three months. Ketryx's team grew 9.9% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A5 investors entered at this stage
Lightspeed Venture Partners
E14 Fund
Ubiquity Ventures
Transformation Capital
Fifty Three Stations
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Ketryx on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Ketryx’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.